Results 301 to 310 of about 1,833,442 (372)
Timely Updating on Ber/Geo/1/2 Queue Modeled Status Updating System with Eavesdropper. [PDF]
Zhang J +5 more
europepmc +1 more source
CXCR1 Depletion in Ly6C+ cDC2 Alleviates Acute Lung Injury via Modulation of Th17/Treg Balance
Pro‐inflammatory Ly6C⁺ cDC2s are identified as key effector cells mediating Cxcr1 signaling, driving the progression of ALI. Ly6C⁺ cDC2s release high levels of Il‐6 and Il‐1β, inducing Th17 differentiation. Cxcr1 deficiency reduces Il‐6 and Il‐1β production from Ly6C⁺ cDC2s through suppressing MEK1/ERK /NF‐κB signaling, thereby shifts naïve T cells ...
Shenghui Li +8 more
wiley +1 more source
The prognostic model based on tumor-associated neutrophils contributes to the stromal landscape and influences metabolic reprogramming in colorectal cancer. [PDF]
Yin X +5 more
europepmc +1 more source
PPP1R3B induces anti‐inflammatory M2 macrophage polarization and maintains energy supply in plaques. Its absence accelerates plaque progression. PPP1R3B regulates M2 macrophage polarization and energy metabolism via phosphorylated STAT3 (p‐STAT3), which plays a dual role by activating anti‐inflammatory transcriptional programs through the PPAR‐γ/PGC‐1α/
Lin Shen +12 more
wiley +1 more source
Regulation of Water Balance of the Plant from the Different Geo-Environmental Locations
Astghik Sukiasyan
openalex +2 more sources
openaire +3 more sources
Expression and prognosis of CXCL13 in uterine corpus endometrial carcinoma based on bioinformatics analysis. [PDF]
Wang Z, Gao Y.
europepmc +1 more source
FMO2 Promotes Angiogenesis via Regulation of N‐Acetylornithine
This study identifies flavin‐containing monooxygenase 2 (FMO2) as a novel proangiogenic regulator in endothelial cells. Targeted FMO2 ablation impairs vessel sprouting, whereas its compensation potently enhances angiogenesis. Metabolomics and single‐cell sequencing reveal that FMO2 drives vascular growth via the N‐acetylornithine/ATF3/NOTCH1 axis ...
Jingyi Wang +15 more
wiley +1 more source
ZC3H18 regulates alternative splicing and related genes in cervical cancer. [PDF]
Chen W, Liu C, Li S, Xie X, Hu D, Lin Y.
europepmc +1 more source

